Two osteoporosis drugs to prevent breast cancer

Two for the treatment of osteoporosis drugs can lower some women's risk of breast cancer risk But these drugs there may be serious side effects. American University of North Carolina Chapel investigation branch of a study group of more than 13,000 women in the study, Some of these people have been taking tamoxifen (tamoxifen). Researchers found that their risk of breast cancer risk reduction of nearly 50%. Some researchers still suffering from postmenopausal osteoporosis for women raloxifen (raloxifen ) drugs, the results show that their risk of breast cancer risk reduction of 76%. The United States currently has a market tamoxifen sale and raloxifene are still waiting for the listing of the United States Food and Drug Administration's approval. Researchers also found that the two drugs have side effects exist, some of which have side effects can be quite serious. They will have to increase blood clot risk, and can lead to embolism.